Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region - Global Forecast to 2024
Regenerative medicine is the discipline of medicine that focuses on the regeneration or replacement of organs, tissues, and human cells to re-established normal functionality. Regenerative medicine aims to renew or replace cells in human tissues and organs that have been damaged and are unable to function due to injury or illness. It can be attained by encouraging the bodys own cells to heal, or by treating a patient with laboratory-grown cells and tissues. It holds potential to treat previously incurable chronic diseases and conditions, including Alzheimers disease, Parkinsons disease, diabetes, heart disease, renal failure, osteoporosis, and spinal cord injuries, among others. Also, using regenerative medicine, entire organs can potentially be generated for transplantation.
The regenerative medicine market is expected to reach USD 73.4 billion by 2027 from USD 13.3 billion in 2019, at a CAGR of 23.8%. Growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by FDA, increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds among others.
Cell-based immunotherapy & cell therapy products segment dominated the regenerative medicine market in 2019
Based on type, the regenerative medicine market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products. The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.
Musculoskeletal disorders applications segment likely to dominate the market in 2019
Based on application, the regenerative medicine market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. In 2019, the musculoskeletal disorders segment accounted for the largest market share. The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with rising geriatric population.
North America anticipated to account for the largest share of the regenerative medicine market in 2019
The regenerative medicine market in North America is expected account for the largest share globally, also grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine, introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.
Market Dynamics
Driver: Rising Prevalence of Chronic Diseases and Genetic Disorders
Over the last few decades, the incidence and prevalence of chronic diseases such as CVD, cancer, and diabetes and genetic disorders such as cystic fibrosis have increased significantly across the globe. Currently, CVD is the leading cause of death, globally. According to the WHO, around 17.9 million people die each year from CVD, accounting for around 31% of total deaths worldwide. Owing to the growing adoption of sedentary lifestyles, changing dietary habits, and the presence of many people with major risk factors for CVD (such as hypertension and obesity), the incidence CVD to increase significantly in the coming years. Similarly, the incidence and prevalence of cancer and diabetes have increased significantly across the globe over the last few decades, and this trend is expected to continue in the coming years. According to the International Diabetes Federation (IDF), about 415 million people were suffering from diabetes globally in 2015, and this number is expected to reach 642 million by 2040. In 2018, cancer was the second-leading cause of death globally and was responsible for an estimated 9.6 million deaths (Source: WHO).
Opportunity: Rising Demand for Organ Transplantation
Regenerative medicine allows medical professionals to replace broken bones and develop new organs for organ transplant. It also enables them to renew or replace cells in human tissues and organs that have been damaged and are unable to function due to injury or illness. Traditional organ transplant involves the process of replacing a failing or damaged organ in the human body with a new organ. This process involves the risk of rejection as the human body does not accept organs recognized as foreign by the bodys immune system. The organ supply across the globe is insufficient, and the waiting lists for transplants are growing each day. According to the US Department of Health and Human Services, around 123,304 people in the US were waiting for organ transplants in 2015. The US government estimated that about 30 people die each day due to the unavailability of organs for transplant. To combat this concern, researchers are focusing on advancing regenerative medicine for developing organs. The increasing acceptance of regenerative medicine in organ transplants is thus considered as a major opportunity area for market players.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20172024 |
|
Base year considered |
2018 |
|
Forecast period |
20192024 |
|
Forecast units |
Billion (USD) |
|
Segments covered |
Market report covers various cell-based immunotherapy & cell therapy products (products and autologous products), gene therapy products, and tissue-engineered products (scaffolds and others). |
|
Geographies covered |
North America (US and Canada), Europe (Germany, France, UK, Italy, Spain and RoE), Asia Pacific (Japan, China, Australia, India and RoA), and LATAM (Brazil, Mexico and Rest of LATAM) and Middle East and Africa |
|
Companies covered |
Major 10 players covered, including: Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). |
The research report categorizes the regenerative medicine market into the following segments and sub-segments:
Regenerative Medicine Market, by Type
- Cell-based immunotherapy & Cell therapy products
- Allogeneic products
- Autologous products
- Gene therapy products
- Tissue-engineered products
- Scaffold Products
- Other Products
Regenerative Medicine Market, by Application
- Musculoskeletal Disorders
- Wound Care
- Oncology
- Ocular Disorders
- Diabetes
Regenerative Medicine Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- China
- Japan
- Australia
- India
- Rest of Asia (RoA)
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
Key Market Players
Gilead Life (Kite Pharma) (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US) and Wright Medical (US).
Recent Developments
Critical questions the report answers
- What are the growth opportunities in the regenerative medicine market across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of regenerative medicine products. Will this scenario continue during the next five years?
- Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the various regenerative medicine types and their respective market shares in the overall market?
- What are the new trends and advancements in the regenerative medicine market?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology (Page No. - 16)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 23)
4 Premium Insights (Page No. - 26)
4.1 Regenerative Medicine: Market Overview
4.2 Regenerative Medicine Market, By Type & Application (2019)
4.3 Geographical Snapshot of the Regenerative Medicine Market
5 Market Overview (Page No. - 29)
5.1 Introduction
5.2 Clinical Trials for Regenerative Medicine
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Prevalence of Chronic Diseases and Genetic Disorders
5.3.1.2 Rising Government Investments in Regenerative Medicine Research
5.3.1.3 Product Approvals and Growing Pipeline of Regenerative Medicine Products
5.3.2 Restraints
5.3.2.1 Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
5.3.3 Opportunities
5.3.3.1 Implementation of the 21st Century Cures Act
5.3.3.2 Rising Demand for Organ Transplantation
6 Regenerative Medicine Market, By Type (Page No. - 35)
6.1 Introduction
6.2 Cell-Based Immunotherapy & Cell Therapy Products
6.2.1 Allogeneic Products
6.2.2 Autologous Products
6.3 Tissue-Engineered Products
6.3.1 Scaffolds
6.3.2 Other Tissue-Engineered Products
6.4 Gene Therapy Products
7 Regenerative Medicine Market, By Application (Page No. - 43)
7.1 Introduction
7.2 Musculoskeletal Disorders
7.2.1 Musculoskeletal Disorders Segment Will Continue to Dominate the Regenerative Medicine Market in 2024
7.3 Wound Care
7.3.1 Increasing Prevalence of Target Conditions to Drive the Growth of This Application Segment
7.4 Oncology
7.4.1 Increasing Prevalence of Cancer to Support Market Growth
7.5 Ocular Disorders
7.5.1 Growing Number of Product Approvals to Support Market Growth
7.6 Diabetes
7.6.1 Increasing Incidence of Diabetes and the Growing Focus of Companies on Developing Regenerative Medicine for the Treatment of Diabetes are the Key Factors Driving Market Growth
7.7 Other Applications
8 Regenerative Medicine Market, By Region (Page No. - 52)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 US Accounts for the Largest Share of the Regenerative Medicine Market in North America
8.2.2 Canada
8.2.2.1 Increasing R&D Funding for Regenerative Medicine is A Key Factor Influencing the Growth of the Canadian Regenerative Medicine Market
8.3 Europe
8.3.1 UK
8.3.1.1 UK Accounts for the Largest Market Share in the European Market
8.3.2 Germany
8.3.2.1 Germany has A Strong Foundation for R&D, Including Over 1,000 Public and Private Institutions
8.3.3 France
8.3.3.1 Rising R&D Expenditure, A Major Growth Driver in France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Comparatively Lenient Regulations and Rising Geriatric Population Will Drive Market Growth
8.4.2 China
8.4.2.1 Favorable Investments and Government Support Will Contribute to the Growth of the Chinese Market
8.4.3 Australia
8.4.3.1 Strong Research Base and Availability of Funds Will Push Market Growth in Australia
8.4.4 India
8.4.5 RoAPAC
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latam
8.6 Middle East & Africa
9 Competitive Landscape (Page No. - 79)
9.1 Overview
9.2 Market Ranking Analysis, 2017
9.3 Key Strategies
9.3.1 Product Launches
9.4 Competitive Leadership Mapping (2018)
9.4.1 Vendor Inclusion Criteria
9.4.2 Visionary Leaders
9.4.3 Innovators
9.4.4 Dynamic Differentiators
9.4.5 Emerging Companies
9.5 Competitive Leadership Mapping for Start-Ups (2018)
9.5.1 Progressive Companies
9.5.2 Starting Blocks
9.5.3 Responsive Companies
9.5.4 Dynamic Companies
10 Company Profiles (Page No. - 86)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 Novartis AG
10.2 Vericel
10.3 Integra Lifesciences
10.4 Mimedx Group
10.5 Stryker
10.6 Wright Medical
10.7 Spark Therapeutics
10.8 Osiris Therapeutics
10.9 Kite Pharma (Subsidiary of Gilead Sciences)
10.10 Organogenesis
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. - 103)
11.1 Insights From Industry Experts
11.2 Discussion Guide
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details
List of Tables (101 Tables)
Table 1 Few Important Clinical Studies in the Regenerative Medicine Market
Table 2 Cancer Incidence and Mortality, By Region, 20122035
Table 3 Funding for Regenerative Medicine Research By the NIH Under the 21st Century Cures Act
Table 4 NIH Funding for Regenerative Medicine Research in the US, 20142016 (USD Million)
Table 5 California Institute of Regenerative Medicine Funding for Regenerative Medicine Research
Table 6 Number of Companies Operating in the Regenerative Medicine Market, By Region (20142018)
Table 7 Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 8 Few of the Commercialized Cell-Based Immunotherapy & Cell Therapy Products
Table 9 Cell-Based Immunotherapy & Cell Therapy Products Market, By Region, 20172024 (USD Billion)
Table 10 Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 11 Cell-Based Allogeneic Regenerative Medicine
Table 12 Allogeneic Products Market, By Region, 20172024 (USD Billion)
Table 13 Cell-Based Autologous Regenerative Medicine
Table 14 Autologous Products Market, By Region, 20172024 (USD Billion)
Table 15 Few of the Commercialized Tissue-Engineered Products
Table 16 Regenerative Medicine Market for Tissue-Engineered Products, By Type, 20172024 (USD Billion)
Table 17 Regenerative Medicine Market for Tissue-Engineered Products, By Region, 20172024 (USD Billion)
Table 18 Tissue-Engineered Scaffolds Market, By Region, 20172024 (USD Billion)
Table 19 Other Tissue-Engineered Products Market By Region, 20172024 (USD Billion)
Table 20 Few of the Commercialized Gene Therapy Products
Table 21 Regenerative Medicine Market for Gene Therapy Products, By Region, 20172024 (USD Billion)
Table 22 Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 23 Regenerative Medicine Market for Musculoskeletal Disorders, By Region, 20172024 (USD Billion)
Table 24 Regenerative Medicine Products Commercialized for the Treatment of Acute & Chronic Wounds
Table 25 Regenerative Medicine Market for Wound Care, By Region, 20172024 (USD Billion)
Table 26 Number of Cancer Patients, By Type, 20122030
Table 27 Indicative List of Commercialized Regenerative Cell-Based Immunotherapies for the Treatment of Cancer
Table 28 Regenerative Medicine Market for Oncology, By Region, 20172024 (USD Billion)
Table 29 Regenerative Medicine Market for Ocular Disorders, By Region, 20172024 (USD Billion)
Table 30 Regenerative Medicine Market for Diabetes, By Region, 20172024 (USD Billion)
Table 31 Regenerative Medicine Market for Other Applications, By Region, 20172024 (USD Billion)
Table 32 Regenerative Medicine Market, By Region, 20172024 (USD Billion)
Table 33 North America: Regenerative Medicine Market, By Country, 20172024 (USD Billion)
Table 34 North America: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 35 North America: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 36 North America: Regenerative Medicine, By Application, 20172024 (USD Billion)
Table 37 Products With Rmat Designation (As of 2018)
Table 38 US: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 39 US: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 40 US: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 41 Canada: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 42 Canada: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 43 Canada: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 44 Research Funding European Overview
Table 45 Europe: Regenerative Medicine Market, By Country, 20172024 (USD Billion)
Table 46 Europe: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 47 Europe: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 48 Europe: Regenerative Medicine, By Application, 20172024 (USD Billion)
Table 49 UK: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 50 UK: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 51 UK: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 52 Germany: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 53 Germany: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 54 Germany: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 55 France: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 56 France: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 57 France: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 58 Italy: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 59 Italy: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 60 Italy: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 61 Spain: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 62 Spain: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 63 Spain: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 64 RoE: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 65 RoE: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 66 RoE: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 67 APAC: Regenerative Medicine Market, By Country, 20172024 (USD Billion)
Table 68 APAC: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 69 APAC: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 70 APAC: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 71 Japan: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 72 Japan: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 73 Japan: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 74 China: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 75 China: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 76 China: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 77 Australia: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 78 Australia: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 79 Australia: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 80 India: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 81 India: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 82 India: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 83 RoAPAC: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 84 RoAPAC: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 85 RoAPAC: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 86 Latam: Regenerative Medicine Market, By Country, 20172024 (USD Billion)
Table 87 Latam: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 88 Latam: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 89 Latam: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 90 Brazil: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 91 Brazil: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 92 Brazil: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 93 Mexico: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 94 Mexico: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 95 Mexico: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 96 Rest of Latam: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 97 Rest of Latam: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 98 Rest of Latam: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
Table 99 Middle East & Africa: Regenerative Medicine Market, By Type, 20172024 (USD Billion)
Table 100 Middle East & Africa: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 20172024 (USD Billion)
Table 101 Middle East & Africa: Regenerative Medicine Market, By Application, 20172024 (USD Billion)
List of Figures (29 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Regenerative Medicine Market: Bottom-Up Approach
Figure 4 Regenerative Medicine Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Regenerative Medicine Market, By Type, 2019 vs 2024 (USD Billion)
Figure 7 Regenerative Medicine Market, By Application, 2019 vs 2024 (USD Billion)
Figure 8 Regenerative Medicine Market, By Region, 2019 vs 2024 (USD Billion)
Figure 9 Growing Government Investments in Regenerative Medicine Research to Drive Market Growth During the Forecast Period
Figure 10 Musculoskeletal Disorders to Dominate the Regenerative Medicine Market in 2019
Figure 11 Countries in Europe to Register A Higher Growth Rate During the Forecast Period
Figure 12 Regenerative Medicine Market: Drivers, Restraints, and Opportunities
Figure 13 Cell-Based Immunotherapy & Cell Therapy Products Segment to Dominate the Market in 2018
Figure 14 Oncology Segment to Register the Highest Growth in the Regenerative Medicine Market During the Forecast Period
Figure 15 Prevalence of Diabetes, By Region, 2015 vs 2040
Figure 16 North America to Witness the Highest Growth in the Regenerative Medicine Market During the Forecast Period
Figure 17 Investment Levels Quadrupled During 20102016
Figure 18 North America: Regenerative Medicine Market Snapshot
Figure 19 Key Developments in the Regenerative Medicine Market
Figure 20 Regenerative Medicine Market Ranking, By Key Player, 2018
Figure 21 MnM Dive-Vendor Comparison Matrix: Regenerative Medicine Market
Figure 22 MnM Dive-Vendor Comparison Matrix for Start-Ups: Regenerative Medicine Market
Figure 23 Novartis: Company Snapshot
Figure 24 Vericel: Company Snapshot
Figure 25 Integra Lifesciences: Company Snapshot
Figure 26 Mimedx Group: Company Snapshot
Figure 27 Stryker : Company Snapshot
Figure 28 Wright Medical: Company Snapshot
Figure 29 Osiris Therapeutics: Company Snapshot
To get more details on this report, 
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Regenerative Medicine Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Regenerative Medicine Market